A randomized, controlled trial of the effect of allopurinol on left ventricular mass index in hemodialysis patients

Rutherford, E. et al. (2021) A randomized, controlled trial of the effect of allopurinol on left ventricular mass index in hemodialysis patients. Kidney International Reports, 6(1), pp. 146-155. (doi: 10.1016/j.ekir.2020.10.025) (PMID:33358501) (PMCID:PMC7590839)

[img] Text
224274.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

402kB
[img] Text
224274Suppl.pdf - Supplemental Material

555kB

Abstract

Introduction: Increased left ventricular mass index (LVMI) is associated with mortality in end-stage renal disease. LVMI regression may improve outcomes. Allopurinol has reduced LVMI in randomized controlled trials in chronic kidney disease, diabetes, and ischemic heart disease. This study investigated whether allopurinol would regress LVMI in hemodialysis patients. Methods: This was a randomized placebo-controlled double-blind multicenter trial. A total of 80 patients undergoing regular maintenance hemodialysis were recruited from NHS Tayside, NHS Greater Glasgow and Clyde and NHS Ayrshire and Arran in Scotland, UK. Participants were randomly assigned on a 1:1 ratio to 12 months of therapy with allopurinol 300 mg or placebo after each dialysis session. The primary outcome was change in LVMI, as assessed by cardiac magnetic resonance imaging (MRI) at baseline and 12 months. Secondary outcomes were change in BP, flow-mediated dilation (FMD), augmentation indices (AIx), and pulse wave velocity (PWV). Results: A total of 53 patients, with a mean age of 58 years, completed the study and had MRI follow-up data for analysis. Allopurinol did not regress LVMI (change in LVMI: placebo +3.6 ± 10.4 g/m2; allopurinol: +1.6 ± 11 g/m2; P = 0.49). Allopurinol had no demonstrable effect on BP, FMD, AIx, or PWV. Conclusion: Compared with placebo, treatment with allopurinol did not regress LVMI in this trial.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Mark, Professor Patrick and Mangion, Dr Kenneth and Rutherford, Dr Elaine and Woodward, Miss Rosemary and Roditi, Dr Giles and Jardine, Professor Alan
Authors: Rutherford, E., Ireland, S., Mangion, K., Stewart, G. A., MacGregor, M., Roditi, G., Woodward, R., Gandy, S. J., Houston, J. G., Jardine, A., Rauchhaus, P., Witham, M. D., Mark, P. D., and Struthers, A. D.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Kidney International Reports
Publisher:Elsevier
ISSN:2468-0249
ISSN (Online):2468-0249
Published Online:04 December 2020
Copyright Holders:Copyright © 2020 International Society of Nephrology
First Published:First published in Kidney International Reports 6(1): 146-155
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record